Puerto Rico · 86665

Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid in Puerto Rico

Puerto Rico Medicare Avg
$17.77
0% above national avg
National Medicare Avg
$17.73
All states combined
Billed Charge (PR)
$21.11
What providers submit
Est. Commercial (PR)
$39.80
National avg: $39.71
Est. Cash / Self-Pay (PR)
$19.13
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

41
Services in PR
16
Providers
N/A
Min Payment
N/A
Max Payment

Puerto Rico Pricing in Context

In Puerto Rico, CPT code 86665 (Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid) carries an average Medicare payment of $17.77 — 0% above the national benchmark of $17.73. 16 providers across the state submitted claims for this procedure in 2023, performing 41 total services. Individual payments in PR ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Puerto Rico is $21.11, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Puerto Rico sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in Puerto Rico lands near $39.80, with self-pay cash prices typically around $19.13. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid cost in Puerto Rico?

The average Medicare payment for Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid in Puerto Rico is $17.77, which is 0% above the national average of $17.73. Providers in PR typically bill $21.11 for this procedure.

What does Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid cost with insurance in Puerto Rico?

With commercial insurance in Puerto Rico, Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid costs an estimated $39.80. Without insurance, the estimated cash price is $19.13. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid in Puerto Rico?

16 providers in Puerto Rico billed Medicare for Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid in 2023, performing 41 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid cheaper in Puerto Rico than the national average?

No — Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid costs 0% above the national average in Puerto Rico. The state average Medicare payment is $17.77 compared to $17.73 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial